Literature DB >> 18157708

Huntington disease mutation in Venezuela: age of onset, haplotype analyses and geographic aggregation.

Irene Paradisi1, Alba Hernández1, Sergio Arias2.   

Abstract

The aggregation of patients with Huntington's disease (HD) around Lake Maracaibo, Zulia State, Venezuela, is widely recognized, but the epidemiology of HD in the whole country is relatively unstudied. We have examined 279 individuals from 60 unrelated affected families residing in various areas of Venezuela for the presence of CAG repeats and other features associated with HD. The number of expanded repeats in 139 carriers varied from 35 to 112. Based on our examination of 71 symptomatic individuals, we developed a log-transformed regression equation, y= -0.0238x + 2.6616, to enable the prediction of age of onset in asymptomatic carriers. Intragenic haplotypes were constructed with two VNTRs (variable number of tandem repeats) and two SNPs (single nucleotide polymorphisms) in the promoter region as well as CCG repeat and Delta2642 polymorphisms to assess kinship between families. In 43 of 45 tested families, the haplotype on the mutated chromosome was 1;G;C;7;(A). The other haplotypes observed, 1;G;C;7;(B) and 4;G;C;7;(A), were of Peruvian and French origins, respectively. The geographic source of the first affected ancestor was assessed in 54 families from 15 different states. Residents of the states of Miranda, Lara and Táchira, excluding those of Zulia, had a mutated allele prevalence five- to ninefold higher than that of other areas. A low (approx. 1/200,000) prevalence, a wide-spread distribution with aggregation in some states and a likely remote European Caucasoid origin are defining epidemiologic features of HD in Venezuela.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18157708     DOI: 10.1007/s10038-007-0227-1

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  34 in total

1.  [Why is the study of Huntington's disease important in Venezuela?].

Authors:  E Bonilla
Journal:  Invest Clin       Date:  1991       Impact factor: 0.683

2.  CAG repeat number governs the development rate of pathology in Huntington's disease.

Authors:  J B Penney; J P Vonsattel; M E MacDonald; J F Gusella; R H Myers
Journal:  Ann Neurol       Date:  1997-05       Impact factor: 10.422

3.  Huntington disease: DNA analysis in Brazilian population.

Authors:  S Raskin; N Allan; H A Teive; F Cardoso; M S Haddad; G Levi; R Boy; J Lerena Junior; V S Sotomaior; M Janzen-Dück; L B Jardim; F R Fellander; L A Andrade
Journal:  Arq Neuropsiquiatr       Date:  2000-12       Impact factor: 1.420

4.  Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease.

Authors:  D C Rubinsztein; J Leggo; M Chiano; A Dodge; G Norbury; E Rosser; D Craufurd
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

5.  The statistical analysis of mitochondrial DNA polymorphisms: chi 2 and the problem of small samples.

Authors:  D A Roff; P Bentzen
Journal:  Mol Biol Evol       Date:  1989-09       Impact factor: 16.240

6.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Authors: 
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

7.  The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size.

Authors:  R R Brinkman; M M Mezei; J Theilmann; E Almqvist; M R Hayden
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

8.  Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals.

Authors:  J B Penney; A B Young; I Shoulson; S Starosta-Rubenstein; S R Snodgrass; J Sanchez-Ramos; M Ramos-Arroyo; F Gomez; G Penchaszadeh; J Alvir
Journal:  Mov Disord       Date:  1990       Impact factor: 10.338

9.  Ancestral differences in the distribution of the delta 2642 glutamic acid polymorphism is associated with varying CAG repeat lengths on normal chromosomes: insights into the genetic evolution of Huntington disease.

Authors:  E Almqvist; N Spence; K Nichol; S E Andrew; J Vesa; L Peltonen; M Anvret; J Goto; I Kanazawa; Y P Goldberg
Journal:  Hum Mol Genet       Date:  1995-02       Impact factor: 6.150

10.  Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease.

Authors:  R G Snell; J C MacMillan; J P Cheadle; I Fenton; L P Lazarou; P Davies; M E MacDonald; J F Gusella; P S Harper; D J Shaw
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

View more
  17 in total

Review 1.  Regional research priorities in brain and nervous system disorders.

Authors:  Vijayalakshmi Ravindranath; Hoang-Minh Dang; Rodolfo G Goya; Hader Mansour; Vishwajit L Nimgaonkar; Vivienne Ann Russell; Yu Xin
Journal:  Nature       Date:  2015-11-19       Impact factor: 49.962

2.  Marked geographic aggregation of acute intermittent porphyria families carrying mutation Q180X in Venezuelan populations, with description of further mutations.

Authors:  Irene Paradisi; Sergio Arias
Journal:  J Inherit Metab Dis       Date:  2010-10-27       Impact factor: 4.982

3.  Haplotype background, repeat length evolution, and Huntington's disease.

Authors:  Daniel Falush
Journal:  Am J Hum Genet       Date:  2009-12       Impact factor: 11.025

4.  The targetable A1 Huntington disease haplotype has distinct Amerindian and European origins in Latin America.

Authors:  Chris Kay; Indira Tirado-Hurtado; Mario Cornejo-Olivas; Jennifer A Collins; Galen Wright; Miguel Inca-Martinez; Diego Veliz-Otani; Maria E Ketelaar; Ramy A Slama; Colin J Ross; Pilar Mazzetti; Michael R Hayden
Journal:  Eur J Hum Genet       Date:  2016-12-21       Impact factor: 4.246

5.  HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia.

Authors:  Simon C Warby; Henk Visscher; Jennifer A Collins; Crystal N Doty; Catherine Carter; Stefanie L Butland; Anna R Hayden; Ichiro Kanazawa; Colin J Ross; Michael R Hayden
Journal:  Eur J Hum Genet       Date:  2011-01-19       Impact factor: 4.246

6.  Huntington's disease in the United States: Variation by demographic and socioeconomic factors.

Authors:  Emilie Bruzelius; Joseph Scarpa; Yiyi Zhao; Sanjay Basu; James H Faghmous; Aaron Baum
Journal:  Mov Disord       Date:  2019-03-13       Impact factor: 10.338

7.  Wild type huntingtin toxicity in yeast: Implications for the role of amyloid cross-seeding in polyQ diseases.

Authors:  A I Alexandrov; G V Serpionov; V V Kushnirov; M D Ter-Avanesyan
Journal:  Prion       Date:  2016-05-03       Impact factor: 3.931

8.  CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup.

Authors:  Simon C Warby; Alexandre Montpetit; Anna R Hayden; Jeffrey B Carroll; Stefanie L Butland; Henk Visscher; Jennifer A Collins; Alicia Semaka; Thomas J Hudson; Michael R Hayden
Journal:  Am J Hum Genet       Date:  2009-02-26       Impact factor: 11.025

Review 9.  Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors.

Authors:  Raj N Kalaria; Gladys E Maestre; Raul Arizaga; Robert P Friedland; Doug Galasko; Kathleen Hall; José A Luchsinger; Adesola Ogunniyi; Elaine K Perry; Felix Potocnik; Martin Prince; Robert Stewart; Anders Wimo; Zhen-Xin Zhang; Piero Antuono
Journal:  Lancet Neurol       Date:  2008-07-28       Impact factor: 44.182

10.  Huntington's Disease and Striatal Signaling.

Authors:  Emmanuel Roze; Emma Cahill; Elodie Martin; Cecilia Bonnet; Peter Vanhoutte; Sandrine Betuing; Jocelyne Caboche
Journal:  Front Neuroanat       Date:  2011-08-23       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.